Targeting of nanoparticles to the cerebral vasculature after traumatic brain injury
Serena Omo‐Lamai(Translational Therapeutics (United States)), Vladimir R. Muzykantov(Translational Therapeutics (United States)), Douglas H. Smith(Philadelphia University), Liam S. Chase(University of Pennsylvania), Jia Nong(Translational Therapeutics (United States)), Oscar A. Marcos‐Contreras(Translational Therapeutics (United States)), Krupa Savalia(Neurological Surgery), Brian J. Kelley(University of Pennsylvania), Jichuan Wu(University of Pennsylvania), Jean-Pierre Dollé(University of Pennsylvania), Sahily Esteves-Reyes(University of Pennsylvania)
Cited by 12
Related Papers
Control of Endothelial Targeting and Intracellular Delivery of Therapeutic Enzymes by Modulating the Size and Shape of ICAM-1-targeted Carriers
|Molecular Therapy|2008|566
Highly efficient CD4+ T cell targeting and genetic recombination using engineered CD4+ cell-homing mRNA-LNPs
|Molecular Therapy|2021|272
Traumatic Axonal Injury Induces Proteolytic Cleavage of the Voltage-Gated Sodium Channels Modulated by Tetrodotoxin and Protease Inhibitors
|Journal of Neuroscience|2004|217
Physicochemical Targeting of Lipid Nanoparticles to the Lungs Induces Clotting: Mechanisms and Solutions
|Advanced Materials|2024|99
Systemic tumour suppression via the preferential accumulation of erythrocyte-anchored chemokine-encapsulating nanoparticles in lung metastases
|Nature Biomedical Engineering|2020|92